Date: October 19th, 2026
Location: Gerney-Voltaire, France
Type of Activity: Conference / Meeting
The 5th International Symposium for Researchers and Clinicians on Wiskott Aldrich Syndrome (WAS) brings together leading experts, researchers, and clinicians from around the world to explore the latest developments in this rare disease. This full-day event offers a unique opportunity to access cutting-edge research, engage in in-depth discussions, and foster collaborations across the global WAS community.
About the Symposium
Participants will gain valuable insights into both basic and clinical research, novel therapeutic strategies, and emerging approaches in stem-cell and cellular therapies. The scientific programme includes:
- Keynote lectures presenting the most recent advances in research and clinical practice.
- Expert-led discussion panels addressing critical topics in WAS and WASp research.
- Opportunities for participants to present their work and engage in collaborative discussions.
The symposium emphasizes bridging the gap between basic and clinical research, encouraging collaboration among researchers, and inspiring the next generation of scientists and clinicians to focus on WAS. The data and discussions at this meeting are based on unpublished research and are rarely accessible elsewhere.
Organising Committee
- Prof. Fabio Candotti (Lausanne, Switzerland) – President, ESID
- Prof. Michael Albert (Munich, Germany)
- Prof. Lisa Westerberg (Stockholm, Sweden)
- Dr. Francesca Ferrua (Milan, Italy)
- Prof. Maja Stojanovic (Belgrade, Serbia)
- Prof. Mike Recher (Basel, Switzerland)
Partner Organisation:
- Israeli Wiskott Aldrich Syndrome Association (nonprofit patient organization)
This symposium continues the successful tradition of previous events held in London (2014, 2016), Munich (2022), and Milan (2024), with a format that encourages open discussion, expert panels, and collaboration among participants.
More info here.
